Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION\NALTREXONE vs BUTORPHANOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION\NALTREXONE vs BUTORPHANOL: Safety Overview

Metric BUPROPION\NALTREXONE BUTORPHANOL
Total FAERS Reports 7,763 462
Deaths Reported 30 10
Death Rate 0.4% 2.2%
Hospitalizations 628 24
Average Patient Age 50.0 yrs 53.9 yrs
% Female Patients 87.6% 79.2%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A NASAL
Marketing Status N/A Discontinued